Chronic Migraine trials recruiting in Alabama

All Chronic Migraine trials nationally

Cities in Alabama

Recruiting trials in Alabama

• A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
  NCT06810505 · Phase: Phase 3 · Ages: 12 Years to 17 Years · Sex: All (male and female) · Alabama: Huntsville
• A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
  NCT06625060 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Alabama: Birmingham, Huntsville
• Responding With Evidence and Access for Childhood Headaches
  NCT05889624 · Phase: Not applicable (e.g. observational or device study) · Ages: 10 Years to 17 Years · Sex: All (male and female) · Alabama: Birmingham